News / Events
New CEO appointed
Zürich, June 1st, 2021 Ophthorobotics announced today the appointment of Miguel Serrano as CEO
Ophthorobotics today announced that its Board of Directors has appointed Miguel Serrano as Chief Executive Officer and member of the board of directors, effective June 1st, 2021.
He will succeed Prof. Franziska Mathis-Ullrich who served as the CEO since 2016. Serrano previously served as Corporate Vice President at Medtronic.
Miguel has held numerous global leadership roles in healthcare over the last 15 years with a strong record of accomplishments in driving commercial excellence and a proven leader with innovative business vision and the ability to bring people together through a culture of inclusiveness and integrity.
“His vision for healthcare and experience around the world will help Ophthorobotics enter its next chapter of product innovation and growth, leading the expected upcoming launches of our transformative ophthalmic robotic solutions”, said the company.
Regarding his appointment, Miguel Serrano said: "I'm honored to have been chosen to lead the company. The opportunity ahead of us is vast and I am excited to lead and develop Ophthorobotics into the leading partner for robotically- assisted ophthalmic treatments around the world.”
About Ophthorobotics
Ophthorobotics is a swiss technology company, working in close cooperation with leading ophthalmologists and robotic experts at the ETH Zürich on creating transformative treatments for the main ophthalmic diseases, leveraging robotically-assisted technology.
For further information about the company, visit www.ophthorobitcs.com or contact:
contact@ophthorobotics.com
# # #
Zürich, June 1st, 2021
Ophthorobotics will be present at the 33 German International Ophthalmologic Surgeons (DOC) Congress, which is taking place from June 17th to 19th.
Given the COVID sanitary situation, the conference will happen in an online format this year, but Ophthorobotics is proud to continue supporting DOC and be an active participant at this prestigious event.
We will take the opportunity to provide an update and share exciting news about the company.
Over Spring 2021, the company has retaken operations and accelerated the development of its transformative treatments for the main ophthalmic diseases, leveraging robotically-assisted technology.
Ophthorobotics will be on stage on June 18th at 1pm CET on live channel 1. Login can be obtained through:
http://www.doc-nuernberg.de
Roman Ratnaweera has done a magnificent job leading the development of our pre-clinical prototype. After achieving this important milestone, he has decided to travel the world for a while. We wish him only the best and safe travels.
As of October, Roland Dreyfus undertakes the challenging task of technology development and has joined Ophthorobotics on its exciting journey towards the worldwide first assistive injection system for ophthalmology.
CNN Money Anchor Amanda Kayne interviews Franziska Ullrich about the future of robotics eye injections. See the full interview.
Franziska Ullrich presents the future of robotics in the field of ophthalmology at the "Emerging Technologies in Medicine - AI and robotics" conference 2018 at the University Hospital Essen. See more.
Ophthorobotics wins the Pitching Battle at the Swiss Startup Day 2017 on the Medtech stage. Our assistive injection system for ophthalmology convinced the large jury of investors, startup coaches and experts. Big thanks to the organisers and jury for their support!
Ophthorobotics wins the Angels for Ladies Pitching Challenge. We would like to thank the jury and the organisers for the fruitful input and comments.
We are excited to announce that we have been selected as Healthcare track finalists in the 2017 #HTChallenge! @Hello Tomorrow has reviewed 3,000 applications, selected the TOP 500 deep tech startups from around the globe, and now chosen 7 of the most innovative projects in the Healthcare sector - which includes Ophthorobotics!